4.7 Article

Antimicrobial Activity of Solithromycin against Serotyped Macrolide-Resistant Streptococcus pneumoniae Isolates Collected from US Medical Centers in 2012

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 59, 期 4, 页码 2432-2434

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.04568-14

关键词

-

资金

  1. CEMPRA Pharmaceuticals (Chapel Hill, NC)

向作者/读者索取更多资源

Solithromycin, a next-generation macrolide and novel fluoroketolide, was tested against a 2012 collection of serotyped U.S. macrolide-resistant Streptococcus pneumoniae isolates associated with community-acquired bacterial pneumonia (CABP). Against all 272 isolates, solithromycin demonstrated high potency (MIC50/90, 0.06/0.25 mu g/ml), and it inhibited all strains at MICs of <= 0.5 mu g/ml, including the two most prevalent macrolide-resistant serotypes (19A and 35B). These data support the continued clinical development of solithromycin for the treatment of multidrug-resistant CABP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates

Sarah E. Costello, Lalitagauri M. Deshpande, Andrew P. Davis, Rodrigo E. Mendes, Mariana Castanheira

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)

Article Microbiology

Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms

S. J. Ryan Arends, Paul R. Rhomberg, Nicole Cotroneo, Aileen Rubio, Robert K. Flamm, Rodrigo E. Mendes

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Article Immunology

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Daniel J. Diekema, Michael A. Pfaller, Dee Shortridge, Marcus Zervos, Ronald N. Jones

OPEN FORUM INFECTIOUS DISEASES (2019)

Article Immunology

Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016

Dee Shortridge, Ana C. Gales, Jennifer M. Streit, Michael D. Huband, Athanasios Tsakris, Ronald N. Jones

OPEN FORUM INFECTIOUS DISEASES (2019)

Article Oncology

Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015)

Michael A. Pfaller, Helio S. Suter, Dee Shortridge, Mariana Castanheira, Robert K. Flamm, Rodrigo E. Mendes

JOURNAL OF CHEMOTHERAPY (2019)

Article Infectious Diseases

Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016

Leonard R. Duncan, Caitlin J. Smith, Robert K. Flamm, Rodrigo E. Mendes

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)

Article Microbiology

Updating Molecular Diagnostics for Detecting Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Isolates in Blood Culture Bottles

Fred C. Tenover, Isabella A. Tickler, Victoria M. Le, Scott Dewell, Rodrigo E. Mendes, Richard Goering, Megan Farrington, Shirley Maneth, Margaret Noddin

JOURNAL OF CLINICAL MICROBIOLOGY (2019)

Article Microbiology

Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in US Hospitals during 2016 to 2018

Mariana Castanheira, Timothy B. Doyle, Valerie Kantro, Rodrigo E. Mendes, Dee Shortridge

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Editorial Material Microbiology

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)

Jason M. Pogue, Ronald N. Jones, John S. Bradley, David R. Andes, Sujata M. Bhavnani, George L. Drusano, Michael N. Dudley, Robert K. Flamm, Keith A. Rodvold, Paul G. Ambrose

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Microbiology

Ex Vivo Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin after Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects

E. Wenzler, K. M. Meyer, S. C. Bleasdale, M. Sikka, R. E. Mendes, K. L. Bunnell, M. Finnemeyer, S. L. Rosenkranz, L. H. Danziger, K. A. Rodvold

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Microbiology

Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

M. Biagi, X. Tan, T. Wu, M. Jurkovic, A. Vialichka, K. Meyer, R. E. Mendes, E. Wenzler

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Article Immunology

Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients

Paul G. Ambrose, Sujata M. Bhavnani, David R. Andes, John S. Bradley, Robert K. Flamm, Jason M. Pogue, Ronald N. Jones

OPEN FORUM INFECTIOUS DISEASES (2020)

暂无数据